BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #1601BiotechnologyTop Gainers Yesterday
$9.95 −$0.62 (-5.87%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $10.08 +1.31%
Open$10.28
Prev close$10.57
Day range$9.89 – $10.61
Volume7.22M
Market cap$7.96B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership21.2%-0.15 pts vs. prior quarter
Institutions holding347-1 vs. prior quarter
Insider trades (recent)49 buys / 0 sellsNet buying
Short interest5.28% of floatDays to cover 9.4 · as of 30 Oct 2026
Short-sale volume share15.9%5-day average of daily volume

Short-sale volume as % of daily volume

10%16%23%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$14.79M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$5.0MSuper−$9.8MBig−$2.7MMid−$2.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 85.7% of shares outstanding.

Largest holders

  • Robert Duggan71.76%
  • Mahkam Zanganeh4.58%
  • Baker Bros. Advisors LP4.10%
  • Akeso, Inc.4.01%
  • BlackRock1.30%
  • Vanguard Capital Management, LLC1.03%
  • FMR1.02%
  • Vanguard Portfolio Management, LLC0.84%

By investor type

  • Individual/Insider76.77%
  • Mutual Fund9.25%
  • Hedge Fund6.99%
  • Public Company4.45%
  • Private Company0.21%
  • Sovereign Wealth Fund0.18%
  • Government Pension Fund0.07%
  • Insurance Company0.02%

Reported short interest has risen from 4.69% to 5.28% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Bellevue Asset Management AG Mutual Fund 2026/Q4 +2,098,402 0.3%
Citadel Advisors LLC Hedge Fund 2026/Q4 +2,057,873 0.5%
Kynam Capital Management, LP Hedge Fund 2026/Q4 +1,800,000 0.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q4 +1,675,452 0.8%
Two Sigma Investments, LP Hedge Fund 2026/Q4 +1,563,211 0.3%
Vanguard Capital Management, LLC Mutual Fund 2026/Q4 +1,557,761 1.0%
AQR Capital Management Hedge Fund 2026/Q4 +1,410,510 0.2%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q4 +1,402,395 0.7%
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q4 +1,130,537 0.2%
Opaleye Management Inc. Hedge Fund 2026/Q4 +1,051,901 0.1%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q4 +858,078 0.3%
BlackRock Mutual Fund 2026/Q4 +834,709 1.3%
Franklin Resources Mutual Fund 2026/Q4 +812,624 0.1%
Eventide Asset Management, LLC Mutual Fund 2026/Q4 +806,549 0.1%
GMT Capital Corp. Hedge Fund 2026/Q4 +760,800 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
7 Oct 2026 Bhaskar Anand Chief Accounting Officer & Head of Finance Other Acquisition +100,000 – 100,000
11 Jun 2026 Robert Duggan Co-CEO & Executive Chairman Open Market Acquisition +3,810,000 $13.12 573,883,879
3 Jun 2026 Mahkam Zanganeh Co-Chief Executive Officer Open Market Acquisition +100,000 $14.60 36,131,930
3 Jun 2026 Manmeet Soni COO, CFO & Director Open Market Acquisition +50,000 $14.46 3,123,603
7 Jan 2026 Bhaskar Anand Chief Accounting Officer & Head of Finance Other Derivative Acquisition +30,000 $18.83 30,000
1 Jan 2026 Kenneth Clark Lead Independent Director Other Derivative Acquisition +52,796 $17.52 17,796
1 Jan 2026 Robert F. Booth Independent Director Other Derivative Acquisition +42,180 $17.52 7,180
1 Jan 2026 Robert Duggan Co-CEO & Executive Chairman Other Derivative Acquisition +11,232 $17.52 11,232
1 Jan 2026 Jeffrey Huber Independent Director Other Derivative Acquisition +44,885 $17.52 9,885
1 Jan 2026 Mostafa Ronaghi Independent Director Other Derivative Acquisition +35,000 $17.52 35,000
1 Jan 2026 Mahkam Zanganeh Co-Chief Executive Officer Other Derivative Acquisition +11,232 $17.52 11,232
1 Jan 2026 Alessandra Cesano Independent Non-Executive Director Other Derivative Acquisition +38,219 $17.52 3,219
1 Jan 2026 Yu Xia Other Derivative Acquisition +35,000 $17.52 35,000
20 Oct 2025 Robert Duggan Co-CEO & Executive Chairman Private Acquisition +13,980,789 $18.74 570,073,879
20 Oct 2025 Mahkam Zanganeh Co-Chief Executive Officer Private Acquisition +293,488 $18.74 36,031,930
20 Oct 2025 Manmeet Soni COO, CFO & Director Private Acquisition +53,361 $18.74 3,073,603
20 Oct 2025 Akeso, Inc. Private Acquisition +533,617 $18.74 32,057,147
20 Oct 2025 Bhaskar Anand Chief Accounting Officer & Head of Finance Private Acquisition +26,680 $18.74 159,751
17 Sep 2025 Bhaskar Anand Chief Accounting Officer & Head of Finance Other Derivative Acquisition +50,000 $19.23 50,000
10 Sep 2025 Robert Duggan Co-CEO & Executive Chairman Open Market Acquisition +338,394 $18.07 556,093,090

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 42,263,053 5.3% 9.4
15 Oct 2026 40,896,653 5.1% 7.0
30 Sep 2026 41,155,196 5.2% 4.8
15 Sep 2026 41,081,179 5.1% 6.6
31 Aug 2026 41,330,352 5.2% 6.6
14 Aug 2026 37,432,330 4.7% 8.7

Discussion

No comments yet — be the first to weigh in on SMMT.

Sign in to join the discussion.

Scroll to Top